Related references
Note: Only part of the references are listed.Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target
Rene Santer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise A randomized, double-blind, placebo-controlled, phase 3 trial
Ele Ferrannini et al.
DIABETES CARE (2010)
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
Clifford J. Bailey et al.
LANCET (2010)
SGLT2 inhibition - a novel strategy for diabetes treatment
Edward C. Chao et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Glycaemic control in type 2 diabetes: Targets and new therapies
Abd A. Tahrani et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
Abd A. Tahrani et al.
ADVANCES IN THERAPY (2009)
Glucose Control by the Kidney: An Emerging Target in Diabetes
Olivera Marsenic
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Dapagliflozin for the Treatment of Type 2 Diabetes
Arnie McCord Brooks et al.
ANNALS OF PHARMACOTHERAPY (2009)
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
James F. List et al.
DIABETES CARE (2009)
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment
John P. H. Wilding et al.
DIABETES CARE (2009)
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
Adam G. Tabak et al.
LANCET (2009)
DPP-4 Inhibitors in Clinical Practice
Anna I. Palalau et al.
POSTGRADUATE MEDICINE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
Songping Han et al.
DIABETES (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Wei Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Regulatory mechanisms of Na+/glucose cotransporters in renal proximal tubule cells
Y. J. Lee et al.
KIDNEY INTERNATIONAL (2007)
TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin
Hongwei Jiang et al.
DIABETES (2007)
Active sugar transport in health and disease
E. M. Wright et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali et al.
DIABETOLOGIA (2006)
Biologic actions and therapeutic potential of the proglucagon-derived peptides
DJ Drucker
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2005)
Improving glucose management:: Ten steps to get more patients with type 2 diabetes to glycaemic goal -: Recommendations from the Global Partnership for Effective Diabetes Management
S Del Prato et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Long-term outcome of renal glucosuria type 0:: the original patient and his natural history
S Scholl-Bürgi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Amylin agonists: A novel approach in the treatment of diabetes
O Schmitz et al.
DIABETES (2004)
Pathogenesis of type 2 diabetes mellitus
RA DeFronzo
MEDICAL CLINICS OF NORTH AMERICA (2004)
Glucagon and regulation of glucose metabolism
GQ Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
IS Wood et al.
BRITISH JOURNAL OF NUTRITION (2003)
Interaction of nateglinide with KATP channel in β-cells underlies its unique insulinotropic action
SL Hu
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type a diabetes development
C Weyer et al.
DIABETES CARE (2001)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Islet growth and development in the adult
S Bonner-Weir
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Share Paper
